Patient engagement is gaining momentum in the medtech industry, with companies increasingly integrating patient perspectives throughout the product lifecycle—from early ideation to post-market activities. This approach not only ensures that products better align with patient needs and priorities, but also provides a strategic advantage to medtech companies and investors. This session will explore the diverse applications of patient engagement in medtech, highlighting how incorporating patient insights leads to tangible benefits in R&D, investment strategies, regulatory pathways, and market access. Panelists will share firsthand insights on how patient engagement shapes decision-making in clinical development, regulatory submissions, and reimbursement strategies, demonstrating growing impact across the industry. Attendees will discuss the largest barriers and opportunities for medtech companies to leverage and integrate patient experiences, needs, and data meaningfully into investing, regulatory, and access-related decisions.